Cary Street Partners’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,348
Closed -$237K 994
2025
Q4
$237K Buy
+2,348
New +$255K 0.01% 793
2025
Q3
Sell
-1,757
Closed -$211K 936
2025
Q2
$211K Buy
1,757
+2
+0.1% +$267 0.01% 752
2025
Q1
$258K Sell
1,755
-203
-10% -$31K 0.01% 682
2024
Q4
$318K Buy
+1,958
New +$320K 0.01% 609

Other funds holding CLX

Cary Street Partners's CLX Position: Q1 2026 in Review

Cary Street Partners sold out of Clorox (CLX) in Q1 2026, closing a stake of 2,348 shares — an estimated $237K sold.

Cary Street Partners first reported a position in CLX in Q4 2024 and held it in 4 quarters. The position peaked at $318K in Q4 2024. 1,086 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Cary Street Partners reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
  • Cary Street Partners sold 2,348 Clorox shares in Q1 2026, an estimated $237K.
  • Cary Street Partners first reported a position in Clorox in Q4 2024 and held it in 4 quarters.
  • Cary Street Partners's Clorox position peaked at $318K in Q4 2024.
  • 1,086 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Cary Street Partners's 13F filing for Q1 2026, filed 29 Apr 2026.